Responses
Regular and Young Investigator Award Abstracts
Immune-Stimulants and Immune Modulators
1093 CLN-617 combines IL-2 and IL-12 in a single molecule to optimally balance safety and efficacy upon intratumoral injection
Compose a Response to This Article
Other responses
No responses have been published for this article.